Search Images Maps Play YouTube News Gmail Drive More »
My library | Help | Advanced Book Search | Web History | Sign in

Books

Drug-Drug Interactions in Pharmaceutical Development

 (Google eBook)
Front Cover
1 Review
John Wiley & Sons, Mar 5, 2008 - Medical - 216 pages
Drug-Drug Interactions in Pharmaceutical Development comprehensively reviews the relevant science, industrial practice, and regulatory agency positions on drug-drug interactions. It focuses on the evaluation of potential drug-drug interactions, allowing researchers to address risk factors before a drug is put to market. The book covers both clinical and nonclinical aspects for understanding drug-drug interactions as well as in vitro and in vivo studies for use in studying interactions at the drug discovery stage.
  

What people are saying - Write a review

We haven't found any reviews in the usual places.

Related books

Contents

Contributors
xiii
1 In Vitro Evaluation of Metabolic DrugDrug Interactions Concepts and Practice
1
2 In Vitro Approaches to Anticipating Clinical Drug Interactions
31
3 Inhibition of DrugMetabolizing Enzymes and DrugDrug Interactions in Drug Discovery and Development
75
4 MechanismBased CYP Inhibition Enzyme Kinetics Assays and Prediction of Human DrugDrug Interactions
95
5 Genomic Approaches To DrugDrug Interactions
113
6 Transporters and Drug Interactions
131
7 TransporterMediated Drug Interactions Molecular Mechanisms and Clinical Implications
159
8 Recent Case Studies of Clinically Significant DrugDrug Interactions and the Limits of In Vitro Prediction Methodology
195
9 US Regulatory Perspective DrugDrug Interactions
201
10 Herbal Drug InteractionsA Canadian Perspective
227
Index
241
Wiley Series in Drug Discovery and Development
244
Copyright

Common terms and phrases

About the author (2008)

Albert P. Li is the President and CEO of In Vitro ADMET Laboratories, LLC (www.invitroadmet.com), and Advanced Pharmaceutical Sciences, Inc. (www.apsciences.com), and the cofounder, Chairman, and CSO of the ADMET Group (www.admetgroup.com). Dr. Li has over twenty-five years in the drug development industry, is a distinguished international speaker in the field, and has over 150 publications. He has edited several books.

Bibliographic information